Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-yearStrong growth in key commercial metrics, including ...
VIVUS, in collaboration with PharmaAccess, its marketing partner in the Middle East North African (MENA) region, intends to provide healthcare providers with more treatment options to combat this ...
Common side effects of QSYMIA in adults include numbness or tingling in the hands, arms, feet, or face (paraesthesia), dizziness, changes in the way foods taste or loss of taste (dysgeusia ...
It has pointed to a lower tendency to cause taste disturbances (dysgeusia) than other compounds in the class. In the phase 2b SOOTHE trial reported in 2021, camlipixant was shown to be effective ...
Despite meaningful improvements in overall health-related quality of life due to its robust efficacy, a small pilot study showed rapid development of objectively measured and patient-reported ...
Background: Whether people experiencing homelessness (PEH) have different COVID-19 outcomes than housed patients in Canada remains unclear. We sought to ascertain whether rates of in-hospital ...
Alcohol is one of the most widely used substances. Alcohol use accounts for 5.1% of the global disease burden, contributes substantially to societal and economic costs, and leads to approximately 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results